A toxicity study of trimetrexate used in combination with cyclosporine as acute graft-versus-host disease prophylaxis in HLA-mismatched, related donor bone marrow transplants

This study evaluated the acute toxicity of trimetrexate (TMTX) used in combination with cyclosporine (CsA) for prevention of acute graft-versus-host disease (GVHD) in patients undergoing allogeneic marrow transplantation from HLA-mismatched, related donors. TMTX has a mechanism of action similar to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation 1995-07, Vol.60 (1), p.55-58
Hauptverfasser:	DONEY, K. C, STORB, R, WITHERSPOON, R. P, APPELBAUM, F. R, BEACH, K, ANASETTI, C, DEEG, H. J, HANSEN, J. A, MARTIN, P. J, NASH, R. A, SCHUBERT, M. M, SULLIVAN, K. M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Biological and medical sciences Bone Marrow Transplantation Cyclosporine - administration & dosage Cyclosporine - adverse effects Drug Therapy, Combination Graft vs Host Disease - immunology Graft vs Host Disease - mortality Graft vs Host Disease - prevention & control Histocompatibility Testing Humans Immunomodulators Medical sciences Middle Aged Pharmacology. Drug treatments Survival Analysis Trimetrexate - administration & dosage Trimetrexate - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!